Reev, a medical technology startup developing intelligent, lightweight wearable robotics, announced a $9.2 million funding round to accelerate its mission of transforming mobility assistance for patients with movement disorders.
The funding round was led by Newfund Heka, Polytechnique Ventures, and Irdi Capital, with additional support from Techstars and a group of business angels and healthcare operators. Contributors include French soccer player Raphael Varane and knee surgeon Herve Silbert, assembled by Scala Patrimoine, a multi-family office.
The company’s technology portfolio includes two key solutions:
— Reev Sense, a motion sensor system that attaches to a patient’s shoe or leg, delivering precise gait analysis.
— Dreeven, a wearable robotics system using electro-hydraulic technology to provide personalized knee assistance.
With fresh funds in hand Reev aims to address limitations in existing exoskeleton technologies by reducing device weight, lowering costs, and enhancing personalization. The first Dreeven series is expected to launch in 2026.
The funding will also support finalizing Dreeven’s design, conducting a clinical study at the Neuromotor Recovery Lab at Boston University’s Sargent College of Health & Rehabilitation Sciences under the leadership of Dr. Lou Awad, and preparing for U.S. Food and Drug Administration trials.
“With the support of our world-class partners, we are thrilled to enter the next phase of clinical and industrial development,” said Amaury Ciurana, Co-Founder and CEO of Reev “Our innovative technologies, like the DREEVEN motorized orthosis, aim to redefine mobility assistance, transforming lives and reshaping the orthotics industry.”